SCR-1515

N/A

Report date: 2024/12/03 15:10:04
NME

Base Information

Drug NameSCR-1515
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionHepatocyte growth factor receptor inhibitorsVascular endothelial growth factor receptor 2 antagonists
TargetsHepatocyte growth factor receptorVascular endothelial growth factor receptor 2
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaPending
Originator CompaniesSimcere Pharmaceutical Group Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesSimcere Pharmaceutical Group Ltd
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A